Involving patients and the public in all stages of research is becoming increasingly important in order to secure research funding, with many funders even making involvement a condition of funding. More importantly, involving patients and the public in research can make the design stronger, and ensure greater impact from your research.
As part of the Research and Knowledge Exchange Development Framework, RKEO are holding a session on Applying for funding from NIHR – Patient and Public Involvement (PPI). At this session, you’ll he
ar from a Research Fellow / former PPI Senior Programme Manager at the NIHR about what is meant by PPI, and to understand how this can be applied to your research. You’ll also hear from the RDS South West PPI Lead on the importance of involving the public and patients in research.
If you’d like to understand more about what PPI is, and how it can improve your research then come along to this introductory session.
Date: Tuesday 17th October 2017
Time: 09:30-11:30
Venue: Lansdowne Campus
Book your space via the RKE Development Framework page for this event.
For further information, please contact Lisa Gale-Andrews, RKEO Research Facilitator.
Applying for funding from NIHR – Patient and Public Involvement Session 5th April 2017
Supporting patient and public involvement in research










BU Annual Research Conference: Poster Exhibition Call for Applications
Vitae Three Minute Thesis (3MT®) Competition: Applications Now Open
3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease